{"pmid":32488173,"title":"Antimicrobial use, drug-resistant infections and COVID-19.","text":["Antimicrobial use, drug-resistant infections and COVID-19.","Nat Rev Microbiol","Rawson, Timothy M","Ming, Damien","Ahmad, Raheelah","Moore, Luke S P","Holmes, Alison H","32488173"],"journal":"Nat Rev Microbiol","authors":["Rawson, Timothy M","Ming, Damien","Ahmad, Raheelah","Moore, Luke S P","Holmes, Alison H"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32488173","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1038/s41579-020-0395-y","topics":["Treatment"],"weight":1,"_version_":1668623433674522624,"score":9.490897,"similar":[{"pmid":32433531,"title":"Antimicrobial resistance in the age of COVID-19.","text":["Antimicrobial resistance in the age of COVID-19.","Nat Microbiol","32433531"],"journal":"Nat Microbiol","date":"2020-05-21T11:00:00Z","year":2020,"_id":"32433531","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1038/s41564-020-0739-4","weight":0,"_version_":1667342288215343104,"score":54.85523},{"pmid":32423901,"title":"How covid-19 is accelerating the threat of antimicrobial resistance.","text":["How covid-19 is accelerating the threat of antimicrobial resistance.","BMJ","Hsu, Jeremy","32423901"],"journal":"BMJ","authors":["Hsu, Jeremy"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32423901","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1136/bmj.m1983","topics":["General Info"],"weight":1,"_version_":1667352728767037440,"score":51.70543},{"pmid":32463087,"title":"Antimicrobial resistance: the good, the bad, and the ugly.","text":["Antimicrobial resistance: the good, the bad, and the ugly.","As the Royal Society for Biology (RSB) was forming 10 years ago, antimicrobial resistance (AMR) was being heralded as the next threat with a magnitude on a par with global warming. Just a few years later, in 2016, Jim O'Neill's report was published laying out recommendations for tackling drug-resistant infections globally. Where are we now, and what are the challenges ahead? As a slow burner, how will the impact of AMR compare against the recent rapid devastation of the COVID-19 pandemic, and how can we channel some of the good things that come from it (like the awareness and technique of effective hand hygiene) to help us combat AMR speedily and definitively?","Emerg Top Life Sci","Hardie, Kim R","32463087"],"abstract":["As the Royal Society for Biology (RSB) was forming 10 years ago, antimicrobial resistance (AMR) was being heralded as the next threat with a magnitude on a par with global warming. Just a few years later, in 2016, Jim O'Neill's report was published laying out recommendations for tackling drug-resistant infections globally. Where are we now, and what are the challenges ahead? As a slow burner, how will the impact of AMR compare against the recent rapid devastation of the COVID-19 pandemic, and how can we channel some of the good things that come from it (like the awareness and technique of effective hand hygiene) to help us combat AMR speedily and definitively?"],"journal":"Emerg Top Life Sci","authors":["Hardie, Kim R"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32463087","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1042/ETLS20190194","keywords":["antibiotic","antimicrobial resistance","bacteria","biofilms"],"weight":0,"_version_":1668079521543225344,"score":51.70543},{"pmid":32399092,"pmcid":"PMC7217106","title":"Antimicrobial resistance is a global problem - a UK perspective.","text":["Antimicrobial resistance is a global problem - a UK perspective.","Increasingly we are reaching a situation where current antimicrobial medicines are no longer effective for common infections, and antimicrobial resistance (AMR) is becoming a global public health crisis. The reliance on antimicrobials such as antibiotics has become a major issue for both medicine and agriculture, particularly given the slow development of new medicines and pharmaceutical industry investment. The UK government has been working with other international bodies in the search for solutions to the many challenges AMR poses. Herbal medicines may provide a useful modality in the fight against AMR and can work solely or in tandem with current antimicrobial approaches. Recommendations for herbal medicine use during the COVID-19 outbreak have featured in Chinese national guidelines and policies, but UK strategies have no such guidance. More research is urgently needed to explore the biological plausibility and safety of herbal medicines to manage AMR. AMR is universal, affecting anyone and everyone, at any age and in any country. Investigating how such approaches can be integrated into western medicine will be important to elucidate.","Eur J Integr Med","Hu, Xiao-Yang","Logue, Martin","Robinson, Nicola","32399092"],"abstract":["Increasingly we are reaching a situation where current antimicrobial medicines are no longer effective for common infections, and antimicrobial resistance (AMR) is becoming a global public health crisis. The reliance on antimicrobials such as antibiotics has become a major issue for both medicine and agriculture, particularly given the slow development of new medicines and pharmaceutical industry investment. The UK government has been working with other international bodies in the search for solutions to the many challenges AMR poses. Herbal medicines may provide a useful modality in the fight against AMR and can work solely or in tandem with current antimicrobial approaches. Recommendations for herbal medicine use during the COVID-19 outbreak have featured in Chinese national guidelines and policies, but UK strategies have no such guidance. More research is urgently needed to explore the biological plausibility and safety of herbal medicines to manage AMR. AMR is universal, affecting anyone and everyone, at any age and in any country. Investigating how such approaches can be integrated into western medicine will be important to elucidate."],"journal":"Eur J Integr Med","authors":["Hu, Xiao-Yang","Logue, Martin","Robinson, Nicola"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32399092","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.eujim.2020.101136","keywords":["antibiotics","antimicrobial resistance","global health","government response","herbal medicine"],"locations":["GBR","Chinese","GBR","GBR"],"countries":["China","United Kingdom"],"countries_codes":["CHN|China","GBR|United Kingdom"],"topics":["Prevention"],"weight":1,"_version_":1666714494990024705,"score":48.89772},{"pmid":32433765,"title":"COVID-19 and the potential long-term impact on antimicrobial resistance.","text":["COVID-19 and the potential long-term impact on antimicrobial resistance.","The emergence of the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) has required an unprecedented response to control the spread of the infection and protect the most vulnerable within society. Whilst the pandemic has focused society on the threat of emerging infections and hand hygiene, certain infection control and antimicrobial stewardship policies may have to be relaxed. It is unclear whether the unintended consequences of these changes will have a net-positive or -negative impact on rates of antimicrobial resistance. Whilst the urgent focus must be on controlling this pandemic, sustained efforts to address the longer-term global threat of antimicrobial resistance should not be overlooked.","J Antimicrob Chemother","Rawson, Timothy M","Moore, Luke S P","Castro-Sanchez, Enrique","Charani, Esmita","Davies, Frances","Satta, Giovanni","Ellington, Matthew J","Holmes, Alison H","32433765"],"abstract":["The emergence of the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) has required an unprecedented response to control the spread of the infection and protect the most vulnerable within society. Whilst the pandemic has focused society on the threat of emerging infections and hand hygiene, certain infection control and antimicrobial stewardship policies may have to be relaxed. It is unclear whether the unintended consequences of these changes will have a net-positive or -negative impact on rates of antimicrobial resistance. Whilst the urgent focus must be on controlling this pandemic, sustained efforts to address the longer-term global threat of antimicrobial resistance should not be overlooked."],"journal":"J Antimicrob Chemother","authors":["Rawson, Timothy M","Moore, Luke S P","Castro-Sanchez, Enrique","Charani, Esmita","Davies, Frances","Satta, Giovanni","Ellington, Matthew J","Holmes, Alison H"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32433765","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1093/jac/dkaa194","topics":["Prevention"],"weight":1,"_version_":1667342288332783616,"score":46.379227}]}